Genetic susceptibility to head and neck squamous cell carcinoma.

Head-and-neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide, and its incidence is growing. Although environmental carcinogens and carcinogenic viruses are the main etiologic factors, genetic predisposition obviously plays a risk-modulating role, given that not all individuals exposed to these carcinogens experience the disease. This review highlights some aspects of genetic susceptibility to HNSCC: among others, genetic polymorphisms in biotransformation enzymes, DNA repair pathway, apoptotic pathway, human papillomavirus-related pathways, mitochondrial polymorphisms, and polymorphism related to the bilirubin-metabolized pathway. Furthermore, epigenetic variations, familial forms of HNSCC, functional assays for HNSCC risk assessment, and the implications and perspectives of research on genetic susceptibility in HNSCC are discussed.

[1]  R. Millikan,et al.  Effects of polymorphisms in alcohol metabolism and oxidative stress genes on survival from head and neck cancer. , 2013, Cancer epidemiology.

[2]  C. Harris,et al.  Chemical and physical carcinogenesis: advances and perspectives for the 1990s. , 1991, Cancer research.

[3]  A. Dietz,et al.  Tobacco and alcohol and the risk of head and neck cancer , 1992, The clinical investigator.

[4]  C. R. Leemans,et al.  Microarray Analysis of Bleomycin-Exposed Lymphoblastoid Cells for Identifying Cancer Susceptibility Genes , 2006, Molecular Cancer Research.

[5]  J. Meurman,et al.  Oral micro-organisms in the etiology of cancer , 2008, Acta odontologica Scandinavica.

[6]  Z. Zeng,et al.  A Susceptibility Locus at Chromosome 3p21 Linked to Familial Nasopharyngeal Carcinoma , 2004, Cancer Research.

[7]  Q. Wei,et al.  Genetic variants of a BH3‐only pro‐apoptotic gene, PUMA, and risk of HPV16‐associated squamous cell carcinoma of the head and neck , 2012, Molecular carcinogenesis.

[8]  H Tobi,et al.  Genetic susceptibility to head and neck squamous cell carcinoma. , 1996, Journal of the National Cancer Institute.

[9]  P. Sham,et al.  Identification of Genes with Allelic Imbalance on 6p Associated with Nasopharyngeal Carcinoma in Southern Chinese , 2011, PloS one.

[10]  Q. Wei,et al.  Glutathione S-Transferase Polymorphisms and Risk of Second Primary Malignancy after Index Squamous Cell Carcinoma of the Head and Neck , 2009, Cancer Prevention Research.

[11]  T. Hsu.  Genetic instability in the human population: a working hypothesis. , 2008, Hereditas.

[12]  H. Ahsan,et al.  Measures of genotype versus gene products: promise and pitfalls in cancer prevention. , 2003, Carcinogenesis.

[13]  N. Tretyakova,et al.  Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers , 2002, Oncogene.

[14]  S. Baylin,et al.  Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.

[15]  E. Liu,et al.  A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci , 2010, Nature Genetics.

[16]  S. Snyder,et al.  Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. , 2004, Pediatrics.

[17]  Rondi A. Butler,et al.  Mature MicroRNA Sequence Polymorphism in MIR196A2 Is Associated with Risk and Prognosis of Head and Neck Cancer , 2010, Clinical Cancer Research.

[18]  P. Devilee,et al.  Extending the p16-Leiden tumour spectrum by respiratory tract tumours , 2004, Journal of Medical Genetics.

[19]  Hongbing Shen,et al.  Genetic Variations in Key MicroRNA Processing Genes and Risk of Head and Neck Cancer: A Case-Control Study in Chinese Population , 2012, PloS one.

[20]  R. Frey,et al.  Ethanol and acetaldehyde enhance benzo[a]pyrene-DNA adduct formation in human mammary epithelial cells. , 2000, Carcinogenesis.

[21]  Alyce A. Chen,et al.  Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer. , 2009, Carcinogenesis.

[22]  H. Gelboin.  Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. , 1980, Physiological reviews.

[23]  N. Biswas,et al.  Increased risk of oral cancer in relation to common Indian mitochondrial polymorphisms and Autosomal GSTP1 locus , 2007, Cancer.

[24]  A. Naccarati,et al.  Association of serum bilirubin and promoter variations in HMOX1 and UGT1A1 genes with sporadic colorectal cancer , 2012, International journal of cancer.

[25]  Yaoh-Shiang Lin,et al.  Epidemiology of Oral Cavity Cancer in Taiwan with Emphasis on the Role of Betel Nut Chewing , 2005, ORL.

[26]  Q. Wei,et al.  Modifying effect of MDM4 variants on risk of HPV16‐associated squamous cell carcinoma of oropharynx , 2012, Cancer.

[27]  S. Boccia,et al.  A review of genetic epidemiology of head and neck cancer related to polymorphisms in metabolic genes, cell cycle control and alcohol metabolism , 2012, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.

[28]  G. Babcock,et al.  Unconjugated bilirubin induces apoptosis in colon cancer cells by triggering mitochondrial depolarization , 2004, International journal of cancer.

[29]  M. Ingelman-Sundberg,et al.  Ethanol-inducible cytochrome P4502E1: genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease. , 1993, Alcohol.

[30]  H. Kesteloot,et al.  Serum bilirubin and 10-year mortality risk in a Belgian population , 2001, Cancer Causes & Control.

[31]  A. Brøgger,et al.  An inter-Nordic prospective study on cytogenetic endpoints and cancer risk. Nordic Study Group on the Health Risk of Chromosome Damage. , 1990, Cancer genetics and cytogenetics.

[32]  M. Meyn,et al.  Ataxia-telangiectasia and cellular responses to DNA damage. , 1995, Cancer research.

[33]  H. Schwertner,et al.  The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. , 2007, Advances in clinical chemistry.

[34]  Olivia Fletcher,et al.  Architecture of inherited susceptibility to common cancer , 2010, Nature Reviews Cancer.

[35]  M. Spitz,et al.  Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. , 1994, Journal of the National Cancer Institute.

[36]  J. de la Rosa,et al.  Novel germline CDKN2A mutation associated with head and neck squamous cell carcinomas and melanomas , 2013, Head & neck.

[37]  B. Henderson,et al.  Occupational and other non‐dietary risk factors for nasopharyngeal carcinoma in Guangzhou, China , 1990, International journal of cancer.

[38]  K. Ang,et al.  The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms? , 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

[39]  Y. Nakagawa,et al.  Effect of genetic polymorphisms related to DNA repair and the xenobiotic pathway on the prognosis and survival of gastric cancer patients. , 2011, Anticancer research.

[40]  K. Rothman.  Epidemiology of head and neck cancer , 1978, The Laryngoscope.

[41]  W. Foulkes,et al.  Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study , 1996, BMJ.

[42]  P. Brennan,et al.  Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it? , 2002, Carcinogenesis.

[43]  L. Kiemeney,et al.  Mutagen sensitivity in patients with familial and non‐familial urothelial cell carcinoma , 2000, International journal of cancer.

[44]  N. L. La Thangue,et al.  E2F and cell cycle control: a double-edged sword. , 2003, Archives of biochemistry and biophysics.

[45]  E. Ruiz-Pesini,et al.  Maternally inherited susceptibility to cancer. , 2011, Biochimica et biophysica acta.

[46]  L. Lui,et al.  Familial clustering of nasopharyngeal carcinoma. , 1998, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[47]  F. Abubakar,et al.  The distinctive profile of risk factors of nasopharyngeal carcinoma in comparison with other head and neck cancer types , 2008, BMC public health.

[48]  J. Nevins,et al.  Combinatorial gene control involving E2F and E Box family members , 2004, The EMBO journal.

[49]  Keshav K. Singh,et al.  Mitochondrial DNA polymorphism and risk of cancer. , 2009, Methods in molecular biology.

[50]  Shixiu Wu,et al.  Sequence variations of mitochondrial DNA D-loop region are associated with familial nasopharyngeal carcinoma. , 2011, Mitochondrion.

[51]  M. Spitz,et al.  Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[52]  Mu-Kuan Chen,et al.  Survivin SNP-carcinogen Interactions in Oral Cancer , 2012, Journal of dental research.

[53]  T. Pandita,et al.  Evidence of a chromatin basis for increased mutagen sensitivity associated with multiple primary malignancies of the head and neck , 1995, International journal of cancer.

[54]  H. Norppa,et al.  Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity. , 2002, Carcinogenesis.

[55]  Carole Fakhry,et al.  Case-control study of human papillomavirus and oropharyngeal cancer. , 2007, The New England journal of medicine.

[56]  B. Ponder,et al.  Inherited predisposition to cancer. , 1990, Trends in genetics : TIG.

[57]  Yang Zhang,et al.  Functional Polymorphism -31C/G in the Promoter of BIRC5 Gene and Risk of Nasopharyngeal Carcinoma among Chinese , 2011, PloS one.

[58]  S. Bonassi,et al.  Micronuclei frequency in peripheral blood lymphocytes of cancer patients: a meta-analysis. , 2008, Mutation research.

[59]  Andrew P Feinberg,et al.  An integrated epigenetic and genetic approach to common human disease. , 2004, Trends in genetics : TIG.

[60]  W. Peters,et al.  Genetic polymorphism in the conjugating enzyme UGT1A1 and the risk of head and neck cancer , 2010, International journal of cancer.

[61]  M. Mccarty,et al.  ''Iatrogenic Gilbert syndrome''--a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin. , 2007, Medical hypotheses.

[62]  C. Strassburg.  Pharmacogenetics of Gilbert's syndrome. , 2008, Pharmacogenomics.

[63]  C. McConkey,et al.  Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer—systematic review and meta‐analysis of trends by time and region , 2013, Head & neck.

[64]  Xuemei Ji,et al.  Nasopharyngeal carcinoma risk by histologic type in central China: Impact of smoking, alcohol and family history , 2011, International journal of cancer.

[65]  D. Boomsma,et al.  Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes. , 1999, Journal of the National Cancer Institute.

[66]  Esther Kim,et al.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  Yuhki Yanase,et al.  Germline mutation in ATR in autosomal- dominant oropharyngeal cancer syndrome. , 2012, American journal of human genetics.

[68]  Peter A. Jones,et al.  A decade of exploring the cancer epigenome — biological and translational implications , 2011, Nature Reviews Cancer.

[69]  C. Marsit,et al.  Human Papillomavirus-16 Modifies the Association between Fruit Consumption and Head and Neck Squamous Cell Carcinoma , 2008, Cancer Epidemiology Biomarkers & Prevention.

[70]  R. Parshad,et al.  A deficiency in chromatin repair, genetic instability, and predisposition to cancer. , 1989, Critical reviews in oncogenesis.

[71]  G. Snow,et al.  Association between bleomycin genotoxicity and non-constitutional risk factors for head and neck cancer. , 1993, Cancer letters.

[72]  M. Spitz,et al.  Mutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignancies. , 1990, Journal of the National Cancer Institute.

[73]  G. Snow.  Follow-up in patients treated for head and neck cancer: how frequent, how thorough and for how long? , 1992, European journal of cancer.

[74]  John D Potter,et al.  Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. , 2008, JAMA.

[75]  W. Peters,et al.  Genetic polymorphisms in the tobacco smoke carcinogens detoxifying enzyme UGT1A7 and the risk of head and neck cancer , 2009, Head & neck.

[76]  Zhanjun Guo,et al.  Single nucleotide polymorphisms in the mitochondrial displacement loop and age-at-onset of esophageal squamous cell carcinoma. , 2012, Oncology letters.

[77]  M. Spitz,et al.  Mutagen sensitivity has high heritability: evidence from a twin study. , 2006, Cancer research.

[78]  D. Johnston,et al.  Sensitivity to genotoxic effects of bleomycin in humans: Possible relationship to environmental carcinogenesis , 1989, International journal of cancer.

[79]  F. Zhan,et al.  A common region of allelic loss on chromosome region 3p25.3–26.3 in nasopharyngeal carcinoma , 1998, Genes, chromosomes & cancer.

[80]  G. Snow,et al.  Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[81]  W. Peters,et al.  Genetic polymorphisms of smoking-related carcinogen detoxifying enzymes and head and neck cancer susceptibility. , 2009, Anticancer research.

[82]  Witold Zatonski,et al.  Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. , 2007, Journal of the National Cancer Institute.

[83]  W. Yarbrough,et al.  Familial Head and Neck Cancer: Molecular Analysis of a New Clinical Entity , 2002, The Laryngoscope.

[84]  D. Wallace.  Mitochondria and cancer , 2012, Nature Reviews Cancer.

[85]  J. Hoeijmakers.  Genome maintenance mechanisms for preventing cancer , 2001, Nature.

[86]  W. Kimberling,et al.  Genetic predisposition to breast cancer , 1984, Cancer.

[87]  Q. Tao,et al.  Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments , 2007, Expert Reviews in Molecular Medicine.

[88]  Wei Zhang,et al.  Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. , 2008, Carcinogenesis.

[89]  A. Olshan,et al.  Family history of cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium , 2009, International journal of cancer.

[90]  S. Roberts,et al.  Sensitivity to radiation-induced chromosome damage may be a marker of genetic predisposition in young head and neck cancer patients , 2001, British Journal of Cancer.

[91]  M. Digweed.  Human genetic instability syndromes: single gene defects with increased risk of cancer. , 1993, Toxicology letters.

[92]  Menghong Sun,et al.  A NEIL1 single nucleotide polymorphism (rs4462560) predicts the risk of radiation‐induced toxicities in esophageal cancer patients treated with definitive radiotherapy , 2013, Cancer.

[93]  Q. Wei,et al.  Genetic variants in selected pre‐microRNA genes and the risk of squamous cell carcinoma of the head and neck , 2010, Cancer.

[94]  T. Hsu,et al.  The role of ethanol in oncogenesis of the upper aerodigestive tract; inhibition of DNA repair. , 1991, Anticancer research.

[95]  Keshav K. Singh,et al.  Genetic insights into OXPHOS defect and its role in cancer. , 2011, Biochimica et biophysica acta.

[96]  A. Acha-Sagredo,et al.  Role of cytochrome P-450 genetic polymorphisms in oral carcinogenesis. , 2012, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[97]  M. Lovett,et al.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase. , 1995, Science.

[98]  P. Jongbloet.  Incidence of cancer , 2001, The Lancet.

[99]  S. Hecht.  Environmental tobacco smoke and lung cancer: the emerging role of carcinogen biomarkers and molecular epidemiology. , 1994, Journal of the National Cancer Institute.

[100]  M. Spitz,et al.  Mutagen sensitivity: a biological marker of cancer susceptibility. , 1991, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[101]  Xifeng Wu,et al.  Genetic Variations in Epigenetic Genes Are Predictors of Recurrence in Stage I or II Non–Small Cell Lung Cancer Patients , 2012, Clinical Cancer Research.

[102]  Chien-Jen Chen,et al.  Evaluation of Human Leukocyte Antigen-A (HLA-A), Other Non-HLA Markers on Chromosome 6p21 and Risk of Nasopharyngeal Carcinoma , 2012, PloS one.

[103]  H. Joenje,et al.  The Fanconi Anemia Pathway of Genomic Maintenance , 2006, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[104]  H. Tobi,et al.  The relation between cancer incidence among relatives and the occurrence of multiple primary carcinomas following head and neck cancer. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[105]  H. Raitiola,et al.  Etiological factors of laryngeal cancer. , 1997, Acta oto-laryngologica. Supplementum.

[106]  C. Heath.  Environmental tobacco smoke and lung cancer. , 1993, Lancet.

[107]  William Ignace Wei,et al.  Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue , 2008, Clinical Cancer Research.

[108]  R. Agami,et al.  MicroRNA regulation by RNA-binding proteins and its implications for cancer , 2011, Nature Reviews Cancer.

[109]  N. Caporaso,et al.  Cancer genes: single and susceptibility: exposing the difference. , 1995, Pharmacogenetics.

[110]  Xiang Du,et al.  Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy , 2009, Cancer Chemotherapy and Pharmacology.

[111]  M. Spitz,et al.  A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases. , 1995, Cancer research.

[112]  P. Bosma,et al.  Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. , 1994, The Journal of biological chemistry.

[113]  S. Zhong,et al.  A Genome-Wide Association Study of Upper Aerodigestive Tract Cancers Conducted within the INHANCE Consortium , 2011, PLoS genetics.

[114]  Q. Wei,et al.  Association of TGF-β1 Genetic Variants with HPV16-positive Oropharyngeal Cancer , 2010, Clinical Cancer Research.

[115]  B. Dave,et al.  Nonrandom distribution of mutagen-induced chromosome breaks in lymphocytes of patients with different malignancies. , 1994, International journal of oncology.

[116]  Peter A. Jones,et al.  Overview of cancer epigenetics. , 2005, Seminars in hematology.

[117]  Ruud H. Brakenhoff,et al.  The molecular biology of head and neck cancer , 2011, Nature Reviews Cancer.

[118]  A. Shaha,et al.  Tumours of familial origin in the head and neck. , 2006, Oral oncology.

[119]  Wei Huang,et al.  Comprehensive pathway-based association study of DNA repair gene variants and the risk of nasopharyngeal carcinoma. , 2011, Cancer research.

[120]  T. Powles,et al.  Head and neck cancer in patients with human immunodeficiency virus-1 infection: incidence, outcome and association with Epstein-Barr virus , 2004, The Journal of Laryngology & Otology.

[121]  Q. Wei,et al.  Epidemiology of carcinogen metabolism genes and risk of squamous cell carcinoma of the head and neck , 2007, Head & neck.

[122]  M. Spitz,et al.  DNA repair capacity correlates with mutagen sensitivity in lymphoblastoid cell lines. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[123]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[124]  T. Waldmann,et al.  Enhanced chromatid damage in blood lymphocytes after G2 phase x irradiation, a marker of the ataxia-telangiectasia gene. , 1990, Journal of the National Cancer Institute.

[125]  R. Weber,et al.  A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck. , 2011, Carcinogenesis.

[126]  G. Snow,et al.  Increased mutagen sensitivity in head‐and‐neck squamous‐cell carcinoma patients, particularly those with multiple primary tumors , 1994, International journal of cancer.

[127]  D. Schrenk,et al.  A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers , 1998, European Journal of Clinical Pharmacology.

[128]  K. Hörmann,et al.  Alcohol-related diseases of the mouth and throat. , 2003, Best practice & research. Clinical gastroenterology.

[129]  Y. Xiang,et al.  Non‐dietary risk factors for nasopharyngeal carcinoma in Shanghai, China , 2000, International journal of cancer.

[130]  F. Li,et al.  Interactions of cancer susceptibility genes and environmental carcinogens. American Association for Cancer Research (AACR)-International Agency for Research on Cancer (IARC) Joint Conference. , 1994, Cancer research.

[131]  Peter S Linsley,et al.  MicroRNAs and Cell Cycle Regulation , 2007, Cell cycle.

[132]  G. Snow,et al.  Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. , 1995, Archives of otolaryngology--head & neck surgery.

[133]  V. Preedy,et al.  Demonstration of ethanol-induced protein adducts in oral leukoplakia (pre-cancer) and cancer. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[134]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[135]  S. Powell,et al.  Ataxia telangiectasia: an investigation of the repair defect in the cell line AT5BIVA by plasmid reconstitution. , 1993, Mutation research.

[136]  M. Gillison,et al.  Human papillomavirus in HNSCC: recognition of a distinct disease type. , 2008, Hematology/oncology clinics of North America.

[137]  H. Mohrenweiser,et al.  Symposium overview: genetic polymorphisms in DNA repair and cancer risk. , 2002, Toxicology and applied pharmacology.

[138]  E. Sturgis,et al.  After the smoke clears: environmental and occupational risks for carcinoma of the upper aerodigestive tract. , 2005, Cancer journal.

[139]  T. Hsu.  Genetic predisposition to cancer with special reference to mutagen sensitivity , 1987, In Vitro Cellular & Developmental Biology.

[140]  Douglas F. Easton,et al.  Association studies for finding cancer-susceptibility genetic variants , 2004, Nature Reviews Cancer.

[141]  D Morrell,et al.  Incidence of cancer in 161 families affected by ataxia-telangiectasia. , 1991, The New England journal of medicine.

[142]  E. Feldman.  How grapefruit juice potentiates drug bioavailability. , 2009, Nutrition reviews.

[143]  M. Spitz,et al.  Epidemiology, biology, and chemoprevention of aerodigestive cancer , 1994, Cancer.

[144]  M. Gillison.  Oropharyngeal cancer: a potential consequence of concomitant HPV and HIV infection , 2009, Current opinion in oncology.

[145]  Stephen S. Hecht,et al.  Tobacco carcinogens, their biomarkers and tobacco-induced cancer , 2003, Nature Reviews Cancer.

[146]  S. Gollin,et al.  Polymorphisms in DNA damage response genes and head and neck cancer risk , 2010, Biomarkers.

[147]  A. Acha-Sagredo,et al.  Oral cancer and polymorphism of ethanol metabolising genes. , 2010, Oral oncology.

[148]  Guiying Wang,et al.  Identification of sequence polymorphisms in the D-Loop region of mitochondrial DNA as a risk factor for colon cancer , 2016, Mitochondrial DNA. Part A, DNA mapping, sequencing, and analysis.

[149]  D. Nebert,et al.  Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. , 1982, Pharmacological reviews.

[150]  T. Cotter,et al.  Apoptosis and cancer: the genesis of a research field , 2009, Nature Reviews Cancer.

[151]  H. Thierens,et al.  Chromosomal radiosensitivity in head and neck cancer patients: evidence for genetic predisposition? , 2008, British Journal of Cancer.

[152]  R. Schneider-Stock,et al.  Hereditary p16-Leiden mutation in a patient with multiple head and neck tumors. , 2003, American journal of human genetics.

[153]  K. Walters,et al.  Serum bilirubin and risk of respiratory disease and death. , 2011, JAMA.

[154]  M. Spitz,et al.  Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[155]  C. la Vecchia,et al.  A comparison of the joint effects of alcohol and smoking on the risk of cancer across sites in the upper aerodigestive tract. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[156]  K. Nephew,et al.  Epigenetic gene silencing in cancer initiation and progression. , 2003, Cancer letters.

[157]  M. Spitz,et al.  Genetic susceptibility to cancer: ICRP Publication 79 , 1993, Cancer.

[158]  J. Shah,et al.  High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. , 2003, Archives of otolaryngology--head & neck surgery.

[159]  W. Foulkes,et al.  Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[160]  Laura C. Greaves,et al.  Mitochondrial DNA and disease , 2012, The Journal of pathology.

[161]  Q. Wei,et al.  Combined effects of E2F1 and E2F2 polymorphisms on risk and early onset of squamous cell carcinoma of the head and neck , 2012, Molecular carcinogenesis.